Press Releases

HOUSTON--(BUSINESS WIRE)--Vyripharm Enterprises Inc. and BIZPAC.US hosted the First Annual Vyripharm Public Health and Safety Legislative Reception on August 31, 2022 at the Texas Medical Center (TMC) Institute Innovation Factory, TMC's 1st phase biotech incubator and accelerator.

Since 2012, marijuana has become legal for adult consumption in 16 states and the territory of Washington D.C. Medical marijuana is legal in 36 states at the time that this summary was written. There are currently three other states that have either voted or passed laws that have not gone into effect concerning marijuana consumption.

Raising the Bar for Comprehensive Medical Cannabis and Hemp Testing and Evaluation Vyripharm biopharmaceuticals, a privately held biopharmaceutical company located in the Texas Medical Center in Houston, Texas is pleased to announce that it has been granted patent allowance by the United States Patent and Trade Office for its comprehensive medical cannabis and

HOUSTON–(BUSINESS WIRE)–Vyripharm biopharmaceuticals, a subsidiary of Vyripharm Enterprises, LLC, a privately held company located in the Texas Medical Center in Houston, Texas, announced today that it has signed off on a Master Drug Program Agreement with Regis Technologies, Inc.

HOUSTON–(BUSINESS WIRE)–Vyripharm biopharmaceuticals, a subsidiary of Vyripharm Enterprises, LLC, which is a privately held company located in the Texas Medical Center in Houston Texas, announced today that it will repurpose the development of a novel theranostic platform for the diagnosis, monitoring and treatment of viral infections such as SARS, MERS and

Drag View

VYRIPHARM IS COMMITTED TO:

Helping People Live Better Lives

Quality Assurance and Quality Control is Vyripharm’s focus for enhancing public safety, public health and public awareness.